Washington: Scientists have found a way to help Alzheimer’s drugs seep inside the brain faster – by temporarily breaching its protective shield. The novel experiment was a first attempt in just three patients. But in spots in the brain where the new technology took aim, it enhanced removal of Alzheimer’s trademark brain-clogging plaque, researchers reported … Read more
April 8, 2022 — Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer’s drug aducanumab (Aduhelm) if the patients are participating in clinical trials. On Thursday, the Centers for Medicare & Medicaid Services (CMS) released its national coverage determination for aducanumab and other similar drugs that … Read more
By Robin FosterHealthDay Reporter TUESDAY, July 13, 2021 (Healthday News) — Medicare launched a formal process on Monday that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer’s drug whose high price tag and unproven benefits have prompted widespread controversy. Medicare’s announcement came the same day that leaders of two House committees … Read more